News & Perspective

May 10, 2019

May 10, 2019
international flight

Measles surges in Europe and Tunisia; study identifies at-risk US locations

The WHO is stepping up its response in Europe, as cases surge in Tunisa and researchers plot at-risk US sites.

Jan 18, 2019

Jan 18, 2019
H1N1 influenza

Experts on watch for resistance to new flu drug

Japanese researchers describe two H3N2 flu viruses with mutations that may increase antiviral resistance.

Sep 26, 2018

Sep 26, 2018
Drug researchers

HHS, CDC issue AMR 'challenge' to public, private sectors

More than 100 governments, drug firms, and others have already made commitments.

Sep 05, 2018

Sep 05, 2018
Woman wearing surgical mask

New single-dose antiviral cuts flu symptoms, viral loads

Baloxavir reduced flu symptoms by 1 day and reduced viral shedding.

Feb 09, 2016

Feb 09, 2016
Fever thermometer

Late start to Northern Hemisphere flu season feels strong H1N1 impact

The CDC said it has also received recent reports of severe flu infections linked to 2009 H1N1 in young- and middle-aged adults.

Jul 10, 2015

Jul 10, 2015
DNA fingerprint

Gene study points to Liberian source for new Ebola cluster

The new Ebola disease cluster in Liberia probably was not sparked by an imported case. 

Aug 25, 2014

Aug 25, 2014
WHO Ebola workers

WHO: Medical worker infections and shortages hamper Ebola response

The WHO has heightened concerns about the impact the outbreak is having on frontline workers and the prospects of overseas help.

Apr 08, 2013

Apr 08, 2013

CDC waiting for H7N9 sample to speed test kits

(CIDRAP News) – A human isolate of the novel H7N9 influenza virus from China—needed for the development of diagnostic test kits and related efforts—is expected to arrive at the Centers for Disease Control and Prevention (CDC) within 2 days, a CDC official said today.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»